MAR 07, 2017 6:57 PM PST

Another Step Forward in the Fight Against Breast Cancer

WRITTEN BY: Carmen Leitch

Cancer is most deadly when it spreads from the part of the body where it formed to another part, metastasis. Breast cancer patients are killed not because of breast cancer recurrence, but because it metastasizes; migration to the brain is deadliest for the patient. Researchers at City of Hope have learned more about brain metastases in women suffering from HER-2 positive breast cancer. Around 40 percent of HER-2 positive breast cancers (explained in the video below from the Dana-Farber Cancer Institute) go on to experience brain metastases. Understanding more about the mechanism behind this event will help inform new treatments.

"More women than ever are surviving breast cancer only to die from breast tumors growing in their brains years after they've been declared cancer-free," explained the leader of the study,  Rahul Jandial, M.D., Ph.D., a neurosurgeon and scientist at City of Hope. "I wanted to understand why women with HER2-positive breast cancer (around 20 percent of all breast cancers) have higher rates of brain metastases than women with other breast cancer subtypes and in turn, find their biological Achilles heel to develop new medicines." This work is set to be reported in Clinical & Experimental Metastasis, the journal of the Metastases Research Society.

A protein called reelin that is typically only found in the brain, also encases breast cancer cells, which acts as a shield preventing detection of the cancerous cells. The cells are able to avoid protective mechanisms used by the brain and can then take hold. From their, a dangerous brain tumor can begin to grow.

Following brain surgery, Jandial and his team were able to use the tissue samples remaining after the surgery, comparing those specimens to breast cancer tissue obtained during mastectomies that the same patients had undergone. The investigators found that expression of the reelin protein was low in tissue from primary breast cancer, but in breast cancer that was HER-2 positive and had metastasized to the brain, reel in expression was significantly higher. 

"The cells are essentially able to act as spies that look like citizens," explained Jandial. "They release a mesh of protein and escape the brain's natural defense weapons, causing tumors to grow in the brain."

90 percent of all cancer deaths result from metastases; people that are diagnosed with metastases in the brain have only a 20 percent chance of living a year after their diagnosis. This work will hopefully help patients afflicted with cancer, especially those with metastatic breast cancer.

Metastatic Breast Cancer in Pleural Fluid / Credit: Ed Uthman/Flickr

 

Sources: AAAS/Eurekalert! via City of Hope, Clinical & Experimental Metastasis

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 18, 2020
Cancer
Itraconazole: the key is in the dosage
SEP 18, 2020
Itraconazole: the key is in the dosage
Precision medicine specific to a patient’s genetics or immune system is spearheading new paths of cancer treatment ...
SEP 21, 2020
Cancer
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
SEP 21, 2020
The Protein ETV1 May Act as a Biomarker for Gastrointestinal Cancer
Cancer is an incredibly diverse disease. It has many types and even sub-types, with a vast range of characteristics. Som ...
SEP 30, 2020
Cancer
How to avoid endocrine disrupting chemicals in your life
SEP 30, 2020
How to avoid endocrine disrupting chemicals in your life
While few people actually enjoy reading product labels and ingredients, a new study from Silent Spring Institute suggest ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 16, 2020
Cancer
Chronic jet lag raises cancer risk
OCT 16, 2020
Chronic jet lag raises cancer risk
We all know how horrible it feels to have a bad night of sleep. That feeling is only intensified with jet lag because ou ...
NOV 02, 2020
Cancer
Age impacts response to melanoma treatment
NOV 02, 2020
Age impacts response to melanoma treatment
Research from the Johns Hopkins Kimmel Cancer Center and Johns Hopkins Bloomberg School of Public Health& ...
Loading Comments...